炎症性肠病患者的粪便代谢组及其决定因素
该研究在424例炎症性肠病患者和255例非炎症性肠病对照者的粪便中检测了1684种代谢物及8种短链和支链脂肪酸,发现超过300种分子在患者粪便中丰度存在差异,其中一种鞘脂与L-尿胆素比值可区分炎症性肠病与非炎症性肠病样本(AUC=0.85),并揭示了粪便代谢组与肠道菌群、饮食模式及宿主遗传的关联。
要点
- 炎症性肠病患者粪便中超过300种分子丰度存在差异。
- 鞘脂与L-尿胆素比值区分炎症性肠病与非炎症性肠病的AUC=0.85。
- 粪便代谢组与肠道菌群组成及饮食模式存在关联。
核心结论
- 在大规模分析中,研究识别出炎症性肠病患者代谢组的改变,这些改变独立于饮食和手术史等常被忽视的混杂因素。
- 鉴于微生物组对粪便代谢物的影响,研究结果为未来针对肠道炎症的干预措施铺平了道路。
研究设计与样本
- 研究测量了424例炎症性肠病患者和255例非炎症性肠病对照者粪便样本中的1684种不同粪便代谢物及8种短链和支链脂肪酸。
- 采用回归分析比较病例与对照之间的代谢物浓度,并确定代谢物与参与者生活方式、临床特征及肠道菌群组成的关系。
- 对粪便代谢物水平进行了全基因组关联分析。
主要发现
- 研究识别出超过300种在炎症性肠病患者粪便中丰度存在差异的分子。
- 一种鞘脂与L-尿胆素之间的比值可区分炎症性肠病与非炎症性肠病样本(AUC=0.85)。
- 在菌群失调的患者中发现了胆汁酸池的变化,且粪便代谢组与肠道菌群之间存在强关联,例如瘤胃球菌(Ruminococcus gnavus)丰度与色胺水平呈正相关。
- 研究发现了158个代谢物与饮食模式之间的关联,且NAT2附近的基因多态性与咖啡代谢强关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Inflammatory bowel disease (IBD) is a multifactorial immune-mediated inflammatory disease of the intestine, comprising Crohn's disease and ulcerative colitis. By characterising metabolites in faeces, combined with faecal metagenomics, host genetics and clinical characteristics, we aimed to unravel metabolic alterations in IBD. DESIGN: We measured 1684 different faecal metabolites and 8 short-chain and branched-chain fatty acids in stool samples of 424 patients with IBD and 255 non-IBD controls. Regression analyses were used to compare concentrations of metabolites between cases and controls and determine the relationship between metabolites and each participant's lifestyle, clinical characteristics and gut microbiota composition. Moreover, genome-wide association analysis was conducted on faecal metabolite levels. RESULTS: We identified over 300 molecules that were differentially abundant in the faeces of patients with IBD. The ratio between a sphingolipid and L-urobilin could discriminate between IBD and non-IBD samples (AUC=0.85). We found changes in the bile acid pool in patients with dysbiotic microbial communities and a strong association between faecal metabolome and gut microbiota. For example, the abundance of Ruminococcus gnavus was positively associated with tryptamine levels. In addition, we found 158 associations between metabolites and dietary patterns, and polymorphisms near NAT2 strongly associated with coffee metabolism. CONCLUSION: In this large-scale analysis, we identified alterations in the metabolome of patients with IBD that are independent of commonly overlooked confounders such as diet and surgical history. Considering the influence of the microbiome on faecal metabolites, our results pave the way for future interventions targeting intestinal inflammation.
引用
- Vich Vila A, Hu S, Andreu-Sánchez S, et al. Faecal metabolome and its determinants in inflammatory bowel disease. Gut. 2023. PMID: 36958817. doi:10.1136/gutjnl-2022-328048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。